BioCentury | Apr 21, 2017
Company News

LifeCodexx, Charite Universitaetsmedizin Berlin deal

...assay within the coming year. LifeCodexx and University Hospital Wuerzburg recently demonstrated clinical proof-of-principle for LifeCodexx’s...
...non-affected patients. The company declined to disclose financial terms. GATC Biotech AG , Konstanz, Germany LifeCodexx AG...
...Konstanz, Germany Charité - Universitäetsmedizin Berlin , Berlin, Germany Business: Diagnostic Julian Zhu Charite - Universitaetsmedizin Berlin LifeCodexx...
BioCentury | Jul 14, 2014
Clinical News

Trisomy 21 test regulatory update

...GATC Biotech AG’s LifeCodexx AG subsidiary said Germany’s Federal Joint Committee (G-BA) issued a positive opinion allowing...
BioCentury | Aug 27, 2012
Company News

GATC sales and marketing update

...GATC Biotech's LifeCodexx AG subsidiary launched PraenaTest in Germany, Switzerland, Austria and Liechtenstein to detect fetal trisomy...
...CHF1,500 ($1,542.90) in Switzerland and Liechtenstein. Last year, Sequenom Inc. (NASDAQ:SQNM, San Diego, Calif.) granted LifeCodexx...
BioCentury | Apr 30, 2012
Clinical News

Trisomy 21 test diagnostic data

...GATC Biotech's LifeCodexx AG subsidiary reported data from a European validation study in 522 maternal blood samples...
...trisomy 21. Data will be presented at various medical meetings over the next few months. LifeCodexx...
...in Germany, Switzerland, Austria and Liechtenstein. Last year, Sequenom Inc. (NASDAQ:SQNM, San Diego, Calif.) granted LifeCodexx...
BioCentury | Apr 28, 2012
Clinical News

LifeCodexx reports validation data for trisomy 21 test

...samples from pregnant women with a high risk of chromosomal alterations in their unborn child. LifeCodexx...
...available this quarter in Germany, Switzerland, Austria and Liechtenstein. Last year, Sequenom Inc. (NASDAQ:SQNM) granted LifeCodexx...
BioCentury | Jan 16, 2012
Clinical News

Trisomy 21 test update

...Biotech's LifeCodexx AG subsidiary obtained over 500 blood samples in a European validation study of its LifeCodexx...
...in German-speaking countries next quarter. GATC Biotech AG , Konstanz, Germany Product: Trisomy 21 test (LifeCodexx...
BioCentury | Aug 15, 2011
Company News

GATC, Sequenom deal

...Sequenom granted GATC Biotech's LifeCodexx AG subsidiary European rights to patents covering the development of prenatal aneuploidy...
BioCentury | Aug 15, 2011
Finance

Highlights of weekly biotech stock moves

...in maternal urine for noninvasive prenatal and cancer diagnostics (see B24) . Separately, Sequenom granted LifeCodexx AG...
...Switzerland and Liechtenstein. Sequenom will receive an undisclosed upfront payment and is eligible for royalties. LifeCodexx...
BioCentury | Jul 4, 2011
Clinical News

Trisomy 21 test update

...GATC Biotech's LifeCodexx AG subsidiary began a European validation study of its Trisomy 21 diagnostic test in...
Items per page:
1 - 9 of 9
BioCentury | Apr 21, 2017
Company News

LifeCodexx, Charite Universitaetsmedizin Berlin deal

...assay within the coming year. LifeCodexx and University Hospital Wuerzburg recently demonstrated clinical proof-of-principle for LifeCodexx’s...
...non-affected patients. The company declined to disclose financial terms. GATC Biotech AG , Konstanz, Germany LifeCodexx AG...
...Konstanz, Germany Charité - Universitäetsmedizin Berlin , Berlin, Germany Business: Diagnostic Julian Zhu Charite - Universitaetsmedizin Berlin LifeCodexx...
BioCentury | Jul 14, 2014
Clinical News

Trisomy 21 test regulatory update

...GATC Biotech AG’s LifeCodexx AG subsidiary said Germany’s Federal Joint Committee (G-BA) issued a positive opinion allowing...
BioCentury | Aug 27, 2012
Company News

GATC sales and marketing update

...GATC Biotech's LifeCodexx AG subsidiary launched PraenaTest in Germany, Switzerland, Austria and Liechtenstein to detect fetal trisomy...
...CHF1,500 ($1,542.90) in Switzerland and Liechtenstein. Last year, Sequenom Inc. (NASDAQ:SQNM, San Diego, Calif.) granted LifeCodexx...
BioCentury | Apr 30, 2012
Clinical News

Trisomy 21 test diagnostic data

...GATC Biotech's LifeCodexx AG subsidiary reported data from a European validation study in 522 maternal blood samples...
...trisomy 21. Data will be presented at various medical meetings over the next few months. LifeCodexx...
...in Germany, Switzerland, Austria and Liechtenstein. Last year, Sequenom Inc. (NASDAQ:SQNM, San Diego, Calif.) granted LifeCodexx...
BioCentury | Apr 28, 2012
Clinical News

LifeCodexx reports validation data for trisomy 21 test

...samples from pregnant women with a high risk of chromosomal alterations in their unborn child. LifeCodexx...
...available this quarter in Germany, Switzerland, Austria and Liechtenstein. Last year, Sequenom Inc. (NASDAQ:SQNM) granted LifeCodexx...
BioCentury | Jan 16, 2012
Clinical News

Trisomy 21 test update

...Biotech's LifeCodexx AG subsidiary obtained over 500 blood samples in a European validation study of its LifeCodexx...
...in German-speaking countries next quarter. GATC Biotech AG , Konstanz, Germany Product: Trisomy 21 test (LifeCodexx...
BioCentury | Aug 15, 2011
Company News

GATC, Sequenom deal

...Sequenom granted GATC Biotech's LifeCodexx AG subsidiary European rights to patents covering the development of prenatal aneuploidy...
BioCentury | Aug 15, 2011
Finance

Highlights of weekly biotech stock moves

...in maternal urine for noninvasive prenatal and cancer diagnostics (see B24) . Separately, Sequenom granted LifeCodexx AG...
...Switzerland and Liechtenstein. Sequenom will receive an undisclosed upfront payment and is eligible for royalties. LifeCodexx...
BioCentury | Jul 4, 2011
Clinical News

Trisomy 21 test update

...GATC Biotech's LifeCodexx AG subsidiary began a European validation study of its Trisomy 21 diagnostic test in...
Items per page:
1 - 9 of 9